Gene-edited pig kidney transplanted into a living patient for the first time

In a new test of xenotransplantation, a medical team at Massachusetts General Hospital announced Thursday that, for the first time, it had transplanted a kidney from a CRISPR gene-edited pig into a living patient.

Surgeons performed the milestone procedure over four hours on Saturday, March 16, without complications. The organ recipient, a 62-year-old man named Richard Slayman, had previously received a human kidney transplant, but it failed after about five years, requiring him to resume kidney dialysis in 2023.

As of Thursday morning, Slayman, a manager with the Massachusetts Department of Transportation, was up and walking — he’s up to 20 laps a day around the ward — one of his physicians told STAT. His kidneys are performing well enough that he hasn’t received dialysis since the surgery, said Leonardo Riella, MGH’s medical director for kidney transplants. He is expected to be discharged soon.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In